COVID-19 tests still in demand despite overall decline in confirmed cases: GlobalData

The current GlobalData estimates show that the COVID-19 test market revenue for January 2023 is still equivalent to 70 per cent of the market revenue for December 2020 right when testing was in dire need

Despite all the decreases in confirmed COVID-19 cases there is still a steady demand for COVID-19 tests. To put this in perspective, the current GlobalData estimates show that the COVID-19 test market revenue for January 2023 is still equivalent to 70 per cent of the market revenue for December 2020 right when testing was in dire need.

Aidan Robertson, Medical Analyst, GlobalData comments, “While for many people COVID-19 has become a thing of the past due to vaccine rollouts and health and safety policies, a certain percentage of the population still take these tests to monitor potential infections or in preparation for international travel or in some cases with companies that require employees to provide a negative test to return to work. All of which has resulted in a more resilient market than previously expected.”

Robertson concludes, “Since COVID-19 remains in an endemic status and the behavior of the virus makes long-term immunity difficult, the need for testing is expected to be continue, though not at the same levels shown at the height of the pandemic.”